000 01200 a2200313 4500
005 20250513110700.0
264 0 _c19970116
008 199701s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM199701163360309
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFuster, V
245 0 0 _aPrevention of atherosclerosis in coronary-artery bypass grafts.
_h[electronic resource]
260 _bThe New England journal of medicine
_cJan 1997
300 _a212-3 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAnticholesteremic Agents
_xtherapeutic use
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aCholesterol, LDL
_xblood
650 0 4 _aCoronary Artery Bypass
650 0 4 _aCoronary Artery Disease
_xprevention & control
650 0 4 _aCoronary Thrombosis
_xprevention & control
650 0 4 _aGraft Occlusion, Vascular
_xprevention & control
650 0 4 _aHumans
650 0 4 _aHypercholesterolemia
_xdrug therapy
700 1 _aVorchheimer, D A
773 0 _tThe New England journal of medicine
_gvol. 336
_gno. 3
_gp. 212-3
856 4 0 _uhttps://doi.org/10.1056/NEJM199701163360309
_zAvailable from publisher's website
999 _c8980346
_d8980346